Business Context and Reporting Period
Company: Harvard Bioscience, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 2, 2019
Reporting Period: The filing announces financial results for the three months ended March 31, 2019.
Key Financial Metrics
The provided text is a cover sheet for a Form 8-K and does not contain specific financial data. It references a press release (Exhibit 99.1) for details on revenue, profit, cash flow, margins, debt, and liquidity. Consequently, no numerical values for these metrics are available in the source text.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. It only indicates that such results were announced via a press release.
Guidance, Outlook, and Management Commentary
Management Action: On May 2, 2019, the company issued a press release and scheduled a conference call for 4:30 PM EST to discuss the results.
Legal Disclaimer: The information in Item 2.02 and the attached press release is furnished but not deemed "filed" under Section 18 of the Exchange Act and is not subject to the liabilities of that section unless expressly incorporated by reference in another filing.
Important Facts for Investor Verification
- Verify the specific financial figures (revenue, net income, EPS) in the referenced Press Release (Exhibit 99.1), as they are not included in this 8-K text.
- Confirm the details of the conference call held on May 2, 2019, for management commentary on the Q1 2019 results.
- Note that the financial data in this filing is not legally "filed" for liability purposes under Section 18 of the Exchange Act.